☰

Marie-Josee Boucher, Ph.D. - Publications

Affiliations: 
2004 Université de Sherbrooke, Sherbrooke, Québec, Canada 
Area:
Cell Biology, Medicine and Surgery
Tree Info Grants Similar researchers PubMed Report error

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Marchand B, Poulin MA, Lawson C, Tai LH, Jean S, Boucher MJ. Gemcitabine promotes autophagy and lysosomal function through ERK- and TFEB-dependent mechanisms. Cell Death Discovery. 9: 45. PMID 36746928 DOI: 10.1038/s41420-023-01342-z  0.403
2019 Marchand B, Boucher M. Abstract 2619: DNA damage agents promote TFEB function and induce pro-survival autophagy signals Cancer Research. 79: 2619-2619. DOI: 10.1158/1538-7445.Am2019-2619  0.358
2015 Marchand B, Arsenault D, Raymond-Fleury A, Boisvert FM, Boucher MJ. Glycogen synthase kinase-3 (GSK3) inhibition induces prosurvival autophagic signals in human pancreatic cancer cells. The Journal of Biological Chemistry. 290: 5592-605. PMID 25561726 DOI: 10.1074/Jbc.M114.616714  0.622
2014 Marchand B, Raymond-Fleury A, Boucher M. Abstract 315: Regulation of the transcription factor TFEB and the autophagic/lysosomal network by GSK3 in pancreatic cancer cells Cancer Research. 74: 315-315. DOI: 10.1158/1538-7445.Am2014-315  0.587
2013 Tremblay I, Paré E, Arsenault D, Douziech M, Boucher MJ. The MEK/ERK pathway promotes NOTCH signalling in pancreatic cancer cells. Plos One. 8: e85502. PMID 24392017 DOI: 10.1371/Journal.Pone.0085502  0.524
2013 Marchand B, Boucher M. Abstract 1674: Inhibition of GSK3 reduces p70S6K activity and promotes autophagy independently of the JNK-cJun pathway. Cancer Research. 73: 1674-1674. DOI: 10.1158/1538-7445.Am2013-1674  0.594
2013 Robert K, Tremblay I, Boucher M. The intracellular domain of Notch1 (NIC1) is hyperphosphorylated following its activation in human pancreatic cancer cells Pancreatology. 13: e68. DOI: 10.1016/j.pan.2012.12.293  0.321
2012 Marchand B, Tremblay I, Cagnol S, Boucher MJ. Inhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanisms. Carcinogenesis. 33: 529-37. PMID 22201186 DOI: 10.1093/Carcin/Bgr309  0.591
2012 Tremblay I, Bintz J, Boucher M. Abstract 1195: Erk activity promotes Notch-dependent HES1 expression in pancreatic cancer cells Cancer Research. 72: 1195-1195. DOI: 10.1158/1538-7445.Am2012-1195  0.596
2011 Lemieux E, Boucher MJ, Mongrain S, Boudreau F, Asselin C, Rivard N. Constitutive activation of the MEK/ERK pathway inhibits intestinal epithelial cell differentiation. American Journal of Physiology. Gastrointestinal and Liver Physiology. 301: G719-30. PMID 21737780 DOI: 10.1152/Ajpgi.00508.2010  0.746
2011 Marchand B, Boucher M. Abstract 2874: Treatment with the autophagy inhibitor 3-Methyladenine sensitizes pancreatic cancer cells to GSK3 inhibition-induced apoptosis Cancer Research. 71: 2874-2874. DOI: 10.1158/1538-7445.Am2011-2874  0.561
2010 Bergeron S, Lemieux E, Durand V, Cagnol S, Carrier JC, Lussier JG, Boucher MJ, Rivard N. The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis. Molecular Cancer. 9: 271. PMID 20942929 DOI: 10.1186/1476-4598-9-271  0.678
2010 Tremblay I, Boucher M. Abstract 1234: Erk-dependent phosphorylation of Notch intracellular domain (NIC) correlates with increased NIC-dependent transcription Cancer Research. 70: 1234-1234. DOI: 10.1158/1538-7445.Am10-1234  0.583
2010 Marchand B, Boucher M. M1967 Inhibition of GSK3 Activity Sensitizes Pancreatic Cancer Cells to TNFα-Induced Apoptosis Gastroenterology. 138: S-449. DOI: 10.1016/S0016-5085(10)62077-X  0.459
2009 Boucher MJ, Simoneau M, Edlund H. The homeodomain-interacting protein kinase 2 regulates insulin promoter factor-1/pancreatic duodenal homeobox-1 transcriptional activity. Endocrinology. 150: 87-97. PMID 18772243 DOI: 10.1210/En.2007-0865  0.461
2009 Marchand B, Boucher M. W1929 Interplay Between GSK3 and JNK Pathways Regulates Human Pancreatic Cancer Cell Survival Gastroenterology. 136: A-756. DOI: 10.1016/S0016-5085(09)63488-0  0.498
2008 Mysliwiec P, Boucher M-. NIC/CSL TRANSCRIPTIONAL ACTIVITY IS REGULATED BY THE MEK/ERK PATHWAY IN HUMAN PANCREATIC CANCER CELLS Pancreas. 37: 486. DOI: 10.1097/01.mpa.0000335346.58579.02  0.482
2008 Marchand B, Boucher M-. GLYCOGEN SYNTHASE KINASE-3 (GSK3) ACTIVITY PLAYS CRUCIAL ROLE IN HUMAN PANCREATIC CANCER CELL PROLIFERATION AND SURVIVAL Pancreas. 37: 483. DOI: 10.1097/01.mpa.0000335332.18675.0a  0.453
2008 Marchand B, Boucher M. M1643 GSK3 Activity Regulates Proliferation and Survival of Human Pancreatic Cancer Cells Gastroenterology. 134: A-388. DOI: 10.1016/S0016-5085(08)61813-2  0.47
2006 Boucher MJ, Selander L, Carlsson L, Edlund H. Phosphorylation marks IPF1/PDX1 protein for degradation by glycogen synthase kinase 3-dependent mechanisms. The Journal of Biological Chemistry. 281: 6395-403. PMID 16407209 DOI: 10.1074/Jbc.M511597200  0.455
2005 Boucher MJ, Laprise P, Rivard N. Cyclic AMP-dependent protein kinase A negatively modulates adherens junction integrity and differentiation of intestinal epithelial cells. Journal of Cellular Physiology. 202: 178-90. PMID 15389533 DOI: 10.1002/Jcp.20104  0.732
2004 Laprise P, Langlois MJ, Boucher MJ, Jobin C, Rivard N. Down-regulation of MEK/ERK signaling by E-cadherin-dependent PI3K/Akt pathway in differentiating intestinal epithelial cells. Journal of Cellular Physiology. 199: 32-9. PMID 14978732 DOI: 10.1002/Jcp.10432  0.758
2004 Boucher MJ, Jean D, Vézina A, Rivard N. Dual role of MEK/ERK signaling in senescence and transformation of intestinal epithelial cells. American Journal of Physiology. Gastrointestinal and Liver Physiology. 286: G736-46. PMID 14701721 DOI: 10.1152/Ajpgi.00453.2003  0.756
2003 Boucher MJ, Rivard N. Regulation and role of brush border-associated ERK1/2 in intestinal epithelial cells. Biochemical and Biophysical Research Communications. 311: 121-8. PMID 14575703 DOI: 10.1016/J.Bbrc.2003.09.172  0.73
2003 Boucher M, Rivard N. Constitutive activation of MEK-ERK signalling pathway in human intestinal crypt cells provokes cell cycle arrest associated with accumulation of p21Cip Gastroenterology. 124: A600. DOI: 10.1016/S0016-5085(03)83040-8  0.729
2003 Laprise P, Boucher M, Rivard N. Inhibition of the MEK-ERK pathway by E-cadherin-dependent Akt activity during enterocyte differentiation Gastroenterology. 124: A275. DOI: 10.1016/S0016-5085(03)81379-3  0.678
2002 Laprise P, Chailler P, Houde M, Beaulieu JF, Boucher MJ, Rivard N. Phosphatidylinositol 3-kinase controls human intestinal epithelial cell differentiation by promoting adherens junction assembly and p38 MAPK activation. The Journal of Biological Chemistry. 277: 8226-34. PMID 11756422 DOI: 10.1074/Jbc.M110235200  0.77
2001 Boucher MJ, Duchesne C, Lainé J, Morisset J, Rivard N. cAMP protection of pancreatic cancer cells against apoptosis induced by ERK inhibition. Biochemical and Biophysical Research Communications. 285: 207-16. PMID 11444827 DOI: 10.1006/Bbrc.2001.5147  0.731
2001 Charland S, Boucher MJ, Houde M, Rivard N. Somatostatin inhibits Akt phosphorylation and cell cycle entry, but not p42/p44 mitogen-activated protein (MAP) kinase activation in normal and tumoral pancreatic acinar cells. Endocrinology. 142: 121-8. PMID 11145574 DOI: 10.1210/Endo.142.1.7908  0.72
2001 Boucher M, Duchesne C, Rivard N. cAMP inhibits cell cycle progression and negatively modulates human intestinal cell differentiation Gastroenterology. 120: A498. DOI: 10.1016/S0016-5085(08)82473-0  0.688
2000 Boucher MJ, Morisset J, Vachon PH, Reed JC, Lainé J, Rivard N. MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. Journal of Cellular Biochemistry. 79: 355-69. PMID 10972974 DOI: 10.1002/1097-4644(20001201)79:3<355::Aid-Jcb20>3.0.Co;2-0  0.692
2000 Boucher M, Vezina A, Rivard N. Differential expression and regulation of p42 and p44 map kinase isoforms in human enterocytes Gastroenterology. 118: A546. DOI: 10.1016/S0016-5085(00)84316-4  0.633
1999 Rivard N, Boucher MJ, Asselin C, L'Allemain G. MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells. The American Journal of Physiology. 277: C652-64. PMID 10516095 DOI: 10.1152/Ajpcell.1999.277.4.C652  0.703
Show low-probability matches.